Background Image
Table of Contents Table of Contents
Previous Page  589 / 1498 Next Page
Information
Show Menu
Previous Page 589 / 1498 Next Page
Page Background

R-CVP versus R-CHOP versus R-FM as first-line therapy for

advanced-stage follicular lymphoma: Final results of FOLL05 trial

from the Fondazione Italiana Linfomi (FIL).

Federico et al

J Clin Oncol 2013

• Randomized trial comparing R-CVP with R-CHOP and R-FM.

• 534 patients were enrolled; 30 excluded. Median age 56 years

(range 30-75), 63% stage IV disease, 37% had 3-5 FLIPI and 27%

3-5 FLIPI2 scores.

• ORR (CR+ PR) for whole group was 91% (p=0.247). After median

follow-up of 34 months, 208 events for TTF were recorded;